| 1 |
The telomere-binding protein TRF2 is required for metronomic therapeutic effects of gemcitabine and capecitabine |
|
|
| Wei-Ping Lee,Keng-Hsin Lan,Chung-Pin Li,Yee Chao,Ming-Chih Hou,Han-Chieh Lin,Shou-Dong Lee |
|
| Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017; 1863(4): 917 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
A Commentary: Herbal Medicine Offers Great Potential in Support of Metronomic Cancer Therapy |
|
|
| Clara Bik-San Lau,Chun-Kwok Wong,Ping-Chung Leung |
|
| Journal of Cancer Therapy. 2017; 08(02): 86 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The novel roles of stromal fibroblasts in metronomic chemotherapy: Focusing on cancer stemness and immunity |
|
|
| Wen-Ying Liao,Tze-Sian Chan,Kelvin K. Tsai |
|
| Journal of Cancer Research and Practice. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study |
|
|
| R. M. Wouda,S. E. Hocker,M. L. Higginbotham |
|
| Veterinary and Comparative Oncology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
The use of low-dose metronomic chemotherapy in dogs-insight into a modern cancer field |
|
|
| T. B. Gaspar,J. Henriques,L. Marconato,F. L. Queiroga |
|
| Veterinary and Comparative Oncology. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Immunotherapy for the treatment of breast cancer |
|
|
| Mariela A. Moreno Ayala,Maria Florencia Gottardo,Antonela S. Asad,Camila Zuccato,Alejandro Nicola,Adriana Seilicovich,Marianela Candolfi |
|
| Expert Opinion on Biological Therapy. 2017; 17(7): 797 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model |
|
|
| Amr S. Abu Lila,Naoto Moriyoshi,Masakazu Fukushima,Cheng-Long Huang,Hiromi Wada,Tatsuhiro Ishida |
|
| Cancer Letters. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Combinatorial immunotherapy strategies for hepatocellular carcinoma |
|
|
| Maria Tagliamonte,Annacarmen Petrizzo,Maria Lina Tornesello,Gennaro Ciliberto,Franco M Buonaguro,Luigi Buonaguro |
|
| Current Opinion in Immunology. 2016; 39: 103 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma† |
|
|
| R. Finotello,J. Henriques,S. Sabattini,D. Stefanello,R. Felisberto,S. Pizzoni,R. Ferrari,L. Marconato |
|
| Veterinary and Comparative Oncology. 2016; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Metronomic chemotherapy and nanocarrier platforms |
|
|
| Amr S. Abu Lila,Tatsuhiro Ishida |
|
| Cancer Letters. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells |
|
|
| Ursula Winter,Hebe A. Mena,Soledad Negrotto,Eloisa Arana,Guillem Pascual-Pasto,Viviana Laurent,Mariona Suñol,Guillermo L. Chantada,Angel M. Carcaboso,Paula Schaiquevich,Francesco Bertolini |
|
| PLOS ONE. 2016; 11(7): e0160094 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Cancer vaccines for hepatocellular carcinoma: future directions |
|
|
| Franco M Buonaguro,Luigi Buonaguro |
|
| Immunotherapy. 2016; 8(4): 391 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Refractory Choriocarcinoma: Complete Response With Oral Etoposide |
|
|
| Manikandan Dhanushkodi,Trivadi Ganesan,Tenali Gnana Sagar |
|
| Journal of Global Oncology. 2016; : JGO006049 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Maintenance treatment with oral cyclophosphamide and bevacizumab in patients with recurrent epithelial ovarian cancer |
|
|
| Roberto Petrioli,Giandomenico Roviello,Anna Ida Fiaschi,Letizia Laera,Salvatora Tindara Miano,Daniele Marrelli,Franco Roviello,Vincenzo Bianco,Edoardo Francini |
|
| Future Oncology. 2015; 11(18): 2563 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report |
|
|
| Karolina Vernmark,Maria Albertsson,Bergthor Björnsson,Thomas Gasslander,Per Sandström,Xiao-Feng Sun,Annika Holmqvist |
|
| BMC Cancer. 2015; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance |
|
|
| Irina Kareva,David J. Waxman,Giannoula Lakka Klement |
|
| Cancer Letters. 2015; 358(2): 100 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 17 |
Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma |
|
|
| Zeng Wang-Yuan,Zeng Jiang-Zheng,Yan-Da Lu,Xin-Bao Hao,Tao Hong,Fen Huang,Jun-Hua Lei,Zhi-Hui He,Mei-zhu Huang |
|
| International Journal of Hyperthermia. 2015; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 18 |
Head and neck cancer: metronomic chemotherapy |
|
|
| Francesca De Felice,Daniela Musio,Vincenzo Tombolini |
|
| BMC Cancer. 2015; 15(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 19 |
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study |
|
|
| Gabriella Ferrandina,Giacomo Corrado,Floriana Mascilini,Paola Malaguti,Riccardo Samaritani,Mariagrazia Distefano,Valeria Masciullo,Alessia Di Legge,Antonella Savarese,Giovanni Scambia |
|
| BMC Cancer. 2014; 14(1): 947 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
